228 286

Cited 30 times in

Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma

DC Field Value Language
dc.contributor.author김승업-
dc.date.accessioned2021-09-29T01:24:23Z-
dc.date.available2021-09-29T01:24:23Z-
dc.date.issued2021-07-
dc.identifier.issn2287-2728-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/184344-
dc.description.abstractOver the past several decades, entecavir (ETV) and tenofovir disoproxil fumarate (TDF) have remained the first-line antiviral agents in several international guidelines. These two antiviral agents have shown similar short to intermediateterm efficacy, including virologic, biochemical, serologic, and histologic responses. However, huge controversies regarding the antiviral efficacy of ETV and TDF in preventing the development of hepatocellular carcinoma (HCC) still exist. In this review, we summarized recent studies that compared the treatment efficacy of ETV and TDF in terms of HCC development.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherKorean Association for the Study of the Liver-
dc.relation.isPartOfCLINICAL AND MOLECULAR HEPATOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleEntecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorSung Won Lee-
dc.contributor.googleauthorJonggi Choi-
dc.contributor.googleauthorSeung Up Kim-
dc.contributor.googleauthorYoung-Suk Lim-
dc.identifier.doi10.3350/cmh.2021.0179-
dc.contributor.localIdA00654-
dc.relation.journalcodeJ00557-
dc.identifier.eissn2287-285X-
dc.identifier.pmid34157830-
dc.subject.keywordCarcinoma, Hepatocellular-
dc.subject.keywordEfficacy-
dc.subject.keywordEntecavir-
dc.subject.keywordHepatitis B-
dc.subject.keywordOutcome-
dc.subject.keywordTenofovir-
dc.contributor.alternativeNameKim, Seung Up-
dc.contributor.affiliatedAuthor김승업-
dc.citation.volume27-
dc.citation.number3-
dc.citation.startPage402-
dc.citation.endPage412-
dc.identifier.bibliographicCitationCLINICAL AND MOLECULAR HEPATOLOGY, Vol.27(3) : 402-412, 2021-07-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.